Natural Haemophilus influenzae type B capsular polysaccharide antibodies in 412 infants and children from West Africa (Burkina-Faso) and France: A cross-sectional serosurvey

European Journal of Epidemiology

Volumn 15, Issue 6, 1999, Pages 577-582

  Ballereau, Françoise ^a   Speich, Michelle ^a   Apaire Marchais, Véronique ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Children; ELISA; Haemophilus influenzae type b; Infants; Natural immunity; Vaccination

Indexed keywords

POLYSACCHARIDE; VIRUS ANTIBODY;

ADOLESCENT; AFRICA; ARTICLE; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH SURVEY; HUMAN; IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALE; VACCINATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; BURKINA FASO; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; IMMUNITY, NATURAL; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 0032767661     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007668003578     Document Type: Article

References (30)

1. Sansoni A, Rappuoli R, Viti S, Costantino P, Fanti O, Cellesi C. Immunity to Haemophilus influenzae type b on sample population from central Italy. Vaccine 1992; 10: 627-630.
2. Jordens JZ, Slack MPE. Haemophilus influenzae: Then and now. Eur J Clin Microbiol Infect Dis 1995; 14: 935-948.
3. Robbins JB, Schneerson R, Anderson P, Smith DH. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccines. JAMA 1996; 276: 1181-1185.
4. Catania S, Ronchetti MP, Catania N, Berardelli G, D'Aviera L, Rossi F, et al. Haemophilus influenzae type b meningitis: Pediatric overview. Riv Eur Sci Med Farmacol 1996; 18: 163-167.
5. Van Alphen L, Spanjaard L, van der Ende A, Schuurman I, Dankert J. Effect of nationwide vaccination of 3-month-old infants in the Netherlands with conjugate Haemophilus influenzae type b vaccine: High efficacy and lack of herd immunity. J Pediatr 1997; 131: 869-873.
6. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997; 21: 173-176.
7. Livartowski A, Boucher J, Detournay B, Reinert P. Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France. Vaccine 1996; 14: 495-500.
8. West DJ, Hesley TM, Jonas LC, Feeley LK, Bird SR, Burke P, et al. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Pediatr Infect Dis J 1997; 16: 593-599.
9. Adegbola RA, Mulholland EK, Falade AG, Secka O, Sarge-Njai R, Corrah T, et al. Haemophilus influenzae type b disease in the Western Region of The Gambia: Background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 1996; 16: 103-111.
10. Iwarson S. World-wide strategies for immunization against invasive Haemophilus influenzae type b disease. Vaccine 1993; 11 Suppl 1: S28-S29.
11. Hazlewood M, Nusrat R, Kumararatne DS, Goodall M, Raykundalia C, Gong Wang D, et al. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol 1993; 93: 157-164.
12. Salih MAM, Fredlund H, Hugosson S, Bodin L, Olcén P. Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influezae type b in Sudanese and Swedish children. Epidemiol Infect 1993; 110: 307-316.
13. Scheifele DW, Meekison W, Guasparini R, Roberts A, Barreto L, Thipphawong J, et al. Evaluation of booster doses of Haemophilus influenze type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine 1995; 13: 104-108.
14. Acharya D, Bhave S, Joshi V, Bavdekar A, Pandit A. Haemophilus influenzae type b vaccine in India: Need and timing, immunogenicity and tolerance. Indian Pediatr 1997; 34: 9-15.
15. Kurikka S, Ölander R-M, Eskola J, Käyhty H. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Pediatr Infect Dis J 1996; 15: 530-535.
16. Zepp F, Schmitt H-J, Kaufhold A, Schuind A, Knuf M, Habermehl P, et al. Evidence for induction of polysaccharide specific B-cell-memory in the 1st year of life: Plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate HibDTPa-HBV combined vaccine. Eur J Pediatr 1997; 156: 18-24.
17. Acharya D, Desai A, Nanavaty N, Pandit A, Patel V, Shah J, et al. Evaluation of immunogenicity and tolerance of single dose Haemophilus influenzae type b-(PRP-T) vaccine. Indian Pediatr 1995; 32: 1077-1082.
18. Ulanova M, Hahn-Zoric M, Lau YL, Lucas A, Hanson LA. Expression of Haemophilus influenzae type b idiotype 1 on naturally acquired antibodies. Clin Exp Immunol 1996; 105: 422-428.
19. Levine OS, Granoff DM, Lagos R, Fritzell B, Levine MM. Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age. Vaccine 1997; 15: 325-328.
20. Sutton A, Vann WF, Karpas AB, Stein KE, Schneerson R. An avidin-biotin-based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods 1985; 82: 215-224.
21. Vincent-Ballereau F, Lafleuriel MT, Marchais H, Claudel-Daniel V. Immunité naturelle vis-à-vis d' Haemophilus influenzae b. Etude par méthode ELISA de la distribution des Ig G, Ig G1 et Ig G2 en France et en Afrique. Path Biol 1991; 39: 38-41.
22. Lamotte M. Initiation aux méthodes statistiques en biologie. 2nd ed. Paris (France): Masson, 1971.
23. Commissariat à l'Energie Atomique (France). Statistique appliquée à l'exploitation des mesures. Tome 2. Paris (France): Masson, 1978.
24. Gomez E, Moore A, Sanchez J, Kool J, Castellanos PL, Feris JM, et al. The epidemiology of Haemophilus influenzae type b carriage among infants and young children in Santo Domingo, Dominican Republic. Pediatr Infect Dis J 1998; 17: 782-786.
25. Hugosson S, Silfverdal S-A, Garpenholt Ö, Esbjörner E, Lindquist B, Vilkerfors T, et al. Invasive Haemophilus influenzae disease: Epidemiology and clinical spectrum before large-scale H. influenzae type b vaccination. Scand J Infect Dis 1995; 27: 63-67.
26. Rijkers GT, Sanders LAM, Zegers BJM. Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 1993; 5: 1-21.
27. Silfverdal SA, Bodin L, Hugosson S, Garpenholt Ö, Werner B, Esbjörner E, et al. Protective effect of breastfeeding on invasive Haemophilus influenzae infection: A case-control study in Swedish preschool children. Int J Epidemiol 1997; 26: 443-450.
28. Claesson BA. Epidemiology of invasive Haemophilus influenzae type b disease in Scandinavia. Vaccine 1993; 11(Suppl 1): S30-S33.
29. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, et al. Large-scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: Practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996; 15: 216-222.
30. de Benoist AC, Laurent E, Goulet V. Infections invasives à Haemophilus influenzae, Listeria monocytogenes, méningocoque, pneumocoque, streptocoques group A et groupe B en France en 1997 - Evolution 1991-1997. BEH 1999; No 15: 57-59.